Multiple Indian pharma giants enter the semaglutide market with affordable generic versions for diabetes and weight management, intensifying competition and improving accessibility.
Researchers at CSIR-NIIST create fortified rice with three times more protein and a low glycaemic index using broken rice and food engineering technology.